Company overview

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in 2022 and Fortune's Best Workplaces in BioPharma in 2022.
Founded in 1998
South San Francisco, California, USA
726 employees (36 in marketing)
48% recommend to a friend
53% positive business outlook

Salaries

Typical salary range

$184,500 – $215,250

/ yr

Help build salary transparency at Cytokinetics

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

7 open now

Headcount trend

Company growth over the last 12 months

Headcount +25.8% year over year

Funding

Total funding

$2.4B

Last raise

$650M

Post IPO Debt, 6 months ago

Funding history

Sep 2025

Post IPO Debt Cytokinetics · $650M

May 2024

Post IPO Debt Cytokinetics · $50M

May 2024

Post IPO Equity Cytokinetics · $550M

Jul 2022

Post IPO Debt Cytokinetics · $450M

Jul 2021

Post IPO Equity Cytokinetics · $316.3M

Jul 2020

Post IPO Equity Cytokinetics · $201.3M

Audience

Monthly website visitors
14.4K
Month over month+0.4%
Quarter over quarter-25.8%
Top sourceSearch (51.1%)
Ad budget per month$0.0
Average search rank56.3
Traffic source mix
Search
51.1%
Direct
40.2%
Referral
5.6%
Paid referral
1.7%
Social
1.2%

LinkedIn followers

Follower count and growth

Total followers

44.1K

12-mo growth

+44.5%

Monthly growth

+2.6%

News

Links